neffy is commercially available in the U.S. for the emergency treatment of allergic reactions, including anaphylaxis, in adults and children aged 4 years and older who weigh at least 33 pounds (15 kg) ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
The MarketWatch News Department was not involved in the creation of this content. 34-member international panel led by experts at Cincinnati Children's offers first consensus guidelines that seek to ...
BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Amneal said that the Food and Drug Administration has approved its epinephrine injection in both single and multi-dose vials for hospitals. The Bridgewater, NJ-based biopharmaceutical company said ...
A new mold concept developed by Zahoransky is engineered to accelerate the mass production of housings for insulin pens and auto injectors in a space- and energy-efficient manner. The Z.Sonic turn ...
Auto-injector specialist Ypsomed is hopping on the U.S. manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the ...
I love a peanut butter and tuna sandwich. But when I was a kid, my school outlawed peanuts. My classmate was super allergic to them. So, we had a rule to keep our friend safe. I packed plain tuna fish ...
The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen) for anaphylaxis and other allergic reactions -- and I will be prescribing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback